Poway, CA, United States of America

Eric Gruff

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Inspirna, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Gruff. Retrieved from https://idiyas.com/inventor/eric-gruff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eric Gruff

Introduction

Eric Gruff is an accomplished inventor based in Poway, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations with improved stability. His work has the potential to enhance the efficacy and shelf-life of various pharmaceutically active compounds.

Latest Patents

Eric Gruff holds 1 patent for his innovative work titled "Formulations containing pharmaceutically active compounds with improved stability." This patent addresses the need for more reliable and effective pharmaceutical formulations, which can greatly benefit the healthcare industry.

Career Highlights

Eric is currently employed at Inspirna, Inc., where he continues to push the boundaries of pharmaceutical research. His dedication to improving drug formulations has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Eric has collaborated with notable colleagues, including Eduardo J Martinez and Peter Rix. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Eric Gruff's contributions to pharmaceutical formulations demonstrate his commitment to advancing healthcare through innovation. His work not only showcases his expertise but also highlights the importance of stability in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…